Govt approves Rs 756 crore scheme to treat cataract patients

Published On 2017-03-03 05:37 GMT   |   Update On 2017-03-03 05:37 GMT

New Delhi: With an aim to free India from cataract by 2022, the government has approved a Rs 756 crore scheme to treat over 700 lakh such patients in the next five years. “Big relief to cataract patients: Modi govt approves scheme of Rs 756 crore for the treatment of 786 lakh cataract patients in 5 years,” BJP official twitter handle said, which was re-tweeted by Union Health Minister...

Login or Register to read the full article

New Delhi: With an aim to free India from cataract by 2022, the government has approved a Rs 756 crore scheme to treat over 700 lakh such patients in the next five years. “Big relief to cataract patients: Modi govt approves scheme of Rs 756 crore for the treatment of 786 lakh cataract patients in 5 years,” BJP official twitter handle said, which was re-tweeted by Union Health Minister JP Nadda.


The scheme would render Rs 2,000 as financial assistance for each operation, including cost of lenses. In addition to it, a mobile application will be developed to bring the government, private doctors, clinics and NGOs together for monitoring the endeavour.


The Health Ministry sources said the plan was to put a stop to blindness among people due to cataract and that giving it a time frame of five years would lead to a “focused approach.”


“This has been a part of the national blindness control programme. However, this particular plan is being drawn up which will make it more focused,” they said.


 
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News